Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableEnded earlyNCT03287063
What this trial is testing

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Early research (Phase 1)Study completedNCT04334863
What this trial is testing

WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain TumorMedulloblastomaBrain Metastases
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT01290692
What this trial is testing

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Who this might be right for
Grade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 14
Large-scale testing (Phase 3)Study completedNCT01811121
What this trial is testing

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS

Who this might be right for
Glioblastoma
Hospices Civils de Lyon 170
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Not applicableStudy completedNCT05984667
What this trial is testing

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Who this might be right for
Glioma, MixedMild Neurocognitive DisorderBrain Tumor
Virginia Commonwealth University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04881032
What this trial is testing

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Centre Jean Perrin 66
Early research (Phase 1)Active Not RecruitingNCT04555577
What this trial is testing

Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Active Not RecruitingNCT06780930
What this trial is testing

Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation

Who this might be right for
Residual or Recurrent Grade 2 IDH Mutant Glioma
Servier 57
Not applicableUnknownNCT03225300
What this trial is testing

Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation

Who this might be right for
Glioblastoma MultiformeChemoradiation
Taichung Veterans General Hospital 120
Early research (Phase 1)Study completedNCT00994071
What this trial is testing

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Who this might be right for
MedulloblastomaPontine GliomaEpendymoma+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT03879512
What this trial is testing

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Who this might be right for
Childhood Glioblastoma
Wuerzburg University Hospital 24
Early research (Phase 1)Ended earlyNCT01954030
What this trial is testing

Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure

Who this might be right for
Malignant Glioma (WHO Grade III or IV)
Annick Desjardins 17
Not applicableLooking for participantsNCT07832734
What this trial is testing

Metabolomics and Transcriptomics of Low- and High-Grade Gliomas

Who this might be right for
IDH Wildtype GlioblastomaIDH Mutant Lower-Grade Gliomas
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 220
Testing effectiveness (Phase 2)Study completedNCT02898012
What this trial is testing

Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status

Who this might be right for
Glioblastoma MultiformePrimary Brain Tumor
Assistance Publique - Hôpitaux de Paris 70
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Ended earlyNCT01011231
What this trial is testing

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Who this might be right for
Glioblastoma
University of California, San Francisco 1
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Next Page